5DK3 image
Deposition Date 2015-09-02
Release Date 2015-11-18
Last Version Date 2024-11-13
Entry Detail
PDB ID:
5DK3
Keywords:
Title:
Crystal Structure of Pembrolizumab, a full length IgG4 antibody
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.28 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Light Chain
Chain IDs:A, C (auth: F)
Chain Length:218
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Heavy Chain
Chain IDs:B, D (auth: G)
Chain Length:444
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Peptide-like Molecules
PRD_900003
Primary Citation
Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab.
Nat.Struct.Mol.Biol. 22 953 958 (2015)
PMID: 26595420 DOI: 10.1038/nsmb.3129

Abstact

Immunoglobulin G4 antibodies exhibit unusual properties with important biological consequences. We report the structure of the human full-length IgG4 S228P anti-PD1 antibody pembrolizumab, solved to 2.3-Å resolution. Pembrolizumab is a compact molecule, consistent with the presence of a short hinge region. The Fc domain is glycosylated at the CH2 domain on both chains, but one CH2 domain is rotated 120° with respect to the conformation observed in all reported structures to date, and its glycan chain faces the solvent. We speculate that this new conformation is driven by the shorter hinge. The structure suggests a role for the S228P mutation in preventing the IgG4 arm exchange. In addition, this unusual Fc conformation suggests possible structural diversity between IgG subclasses and shows that use of isolated antibody fragments could mask potentially important interactions, owing to molecular flexibility.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback